why choose us

First received: August 22, 2023

Clinical Trial: PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Muscarinic Receptor Occupancy

Study Type: INTERVENTIONAL


Official Title: A Trial to Evaluate Target Occupancy of Scopolamine at the Muscarinic M1 Receptor

Brief Summary: The purpose of this study is to assess the target occupancy (TO) of scopolamine at M1 Muscarinic Receptors in the brain after single I.V. doses of scopolamine, in healthy control subjects, using the radiotracer [11C]EMO (also known as [11C]LSN3172176).

Read more